Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11850 Mill Rock Road
San Antonio, TX 78230Phone+1 210-639-9500
Summary
- I am a board certified internist and endocrinologist. I completed my education at Columbia University, Cornell Medical School, and the Mayo Clinic. I have participated as a clinical investigator in over 400 trials and have developed, validated, and am commercializing an app for eSource data capture for clinical trials. BREEZE is rigorous, validated, easy to use, and cost-effective for sites, CROs, and sponsors. BREEZE has been thoroughly vetted by FDA inspectors and produces verified source data.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1974 - 1977- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1971 - 1974
Weill Cornell MedicineClass of 1971
Columbia UniversityBA, Pre-Medicine, Political Science, Dean's List, 1963 - 1967
Certifications & Licensure
NY State Medical License 1972 - Present
TX State Medical License 1977 - 2026
MN State Medical License 1972 - 1979- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Consultant Mylan Pharmaceuticals, 2019-2021
- Coordinating Principal Investigator Gelesis Pharmaceutical, 2017-2019
- Member Transcelerate Pharma eSource Committee, 2017-2019
- Join now to see all
Publications & Presentations
PubMed
- 63 citationsErtugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study.Sam Miller, Tania Krumins, Haojin Zhou, Susan Huyck, Jeremy Johnson
Diabetes Therapy. 2018-01-08 - 143 citationsSignificant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteopo...Susan L. Greenspan, Ronald D. Emkey, Henry G. Bone, Stuart R. Weiss, Norman H. Bell
Annals of Internal Medicine. 2002-12-03
Press Mentions
Using an Implementation Science Approach to Build Leader Facilitation Capability in Healthcare: A Novel Approach for Enhancing Action Learning Set FacilitationSeptember 17th, 2021- Nurses at Pittsburgh’s West Penn Hospital Vote to Authorize StrikeJuly 29th, 2021
- Sam Miller Joined System Pools LLC’s TeamJuly 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
